Human growth hormone affects far more than muscle and body fat. Because HGH influences fluid balance, glucose metabolism, connective tissue and multiple hormone systems, too much growth hormone or treatment with synthetic HGH can produce side effects throughout the body.
Some HGH side effects are relatively mild and may be related to fluid retention, particularly when treatment is first started. Others, including changes in blood glucose or persistent neurological symptoms, deserve closer medical attention. The likelihood and severity of side effects can vary considerably depending on the individual, the reason HGH is being used and the amount of growth hormone exposure.
Understanding the difference between expected treatment-related effects, warning signs and the consequences of chronically excessive growth hormone makes it easier to put HGH risks into perspective.
What Are the Most Common HGH Side Effects in Adults?
The side effects most commonly associated with prescription somatropin in adults involve fluid retention. Growth hormone can cause the body to retain additional sodium and extracellular water, which may lead to swelling, stiffness and changes in sensation.
Recognized adult side effects include swelling of the hands or feet, joint pain, muscle discomfort, numbness or tingling and nerve compression symptoms such as carpal tunnel syndrome. These symptoms are often most noticeable during the early stages of growth hormone treatment.
Importantly, many of these effects can be dose dependent. Canadian prescribing information for somatropin notes that adult symptoms related to water retention may occur during the first months of treatment and can improve spontaneously or after the prescribed dose is reduced.
That does not mean persistent symptoms should simply be ignored. Someone receiving prescription HGH should report new or worsening side effects to the healthcare professional supervising treatment.
HGH and Water Retention
Fluid retention is one of the most recognizable effects associated with HGH. Growth hormone can influence sodium handling and extracellular fluid volume, causing the body to hold more water than usual.
This can appear as puffy fingers, swollen ankles or a general feeling of increased fullness. Rings may feel tighter, shoes can feel different and body weight may rise even without a corresponding increase in body fat.
Water retention can also affect how someone interprets changes in physique. Muscles may appear fuller and measurements of lean body mass can increase partly because water is included as fat-free mass. For this reason, an early increase in scale weight or measured lean mass during HGH treatment should not automatically be interpreted as newly built muscle.
Fluid retention is also connected with several other HGH side effects. Increased pressure within tissues can contribute to joint discomfort and can compress nerves, particularly around the wrist.
HGH and Carpal Tunnel Syndrome
Carpal tunnel syndrome is a well-recognized potential side effect of growth hormone treatment in adults. It occurs when the median nerve becomes compressed as it passes through the carpal tunnel in the wrist.
Typical symptoms can include numbness, tingling, burning or weakness affecting the hand and fingers. Symptoms may be particularly noticeable at night or during activities that place the wrist in certain positions.
Growth hormone does not necessarily damage the nerve directly. One proposed mechanism involves increased fluid and tissue volume within the confined space of the carpal tunnel, increasing pressure around the median nerve.
This also helps explain why carpal tunnel symptoms can occur alongside swelling or tingling elsewhere in the hands. In clinical experience with prescribed somatropin, these symptoms may improve when excessive fluid retention resolves or when treatment is adjusted by the prescribing physician.
Persistent numbness, hand weakness or loss of function should be medically assessed rather than automatically assumed to be a harmless HGH side effect. Carpal tunnel syndrome can have many causes unrelated to growth hormone.
Because this is such a commonly searched HGH concern, we will cover HGH and carpal tunnel syndrome in greater detail in a separate guide.
Joint and Muscle Pain
Joint and muscle discomfort are also recognized during growth hormone therapy. Some adults describe stiffness, aching or a feeling of pressure around joints rather than an acute injury-type pain.
Fluid retention appears to contribute to at least some of these symptoms. Changes in connective tissue and extracellular volume may alter how joints and surrounding structures feel, particularly during the early stages of treatment.
Joint pain associated with HGH should not automatically be interpreted as evidence that growth hormone is damaging the joints. At the same time, existing joint or tendon problems should not simply be blamed on HGH without proper evaluation.
Persistent pain, substantial swelling, loss of function or symptoms following an injury require their own assessment regardless of whether someone is receiving growth hormone.
HGH, Numbness and Tingling
Numbness and tingling are sometimes grouped with carpal tunnel syndrome, but abnormal sensations can occur without a confirmed diagnosis of carpal tunnel. Pharmaceutical somatropin information lists paresthesia, or abnormal tingling sensations, among recognized adult adverse effects.
Again, fluid retention and nerve compression are possible contributors. The hands are commonly discussed because the median nerve at the wrist is particularly vulnerable to compression, but sensations can vary between individuals.
New neurological symptoms should not automatically be attributed to HGH. Cervical spine problems, peripheral neuropathy, repetitive strain, diabetes and several other conditions can also produce numbness or tingling.
If symptoms persist, worsen or involve weakness, medical assessment can help determine whether growth hormone is contributing or another condition is responsible.
HGH and Blood Sugar
Growth hormone has an important relationship with insulin. While GH is necessary for normal metabolism, higher growth hormone exposure can reduce insulin sensitivity, meaning the body may need more insulin to control the same amount of blood glucose.
For some people, this produces little obvious change. In susceptible individuals, however, somatropin treatment can reveal previously unrecognized impaired glucose tolerance or diabetes.
Risk is particularly relevant in people who already have metabolic risk factors such as obesity, impaired fasting glucose, a strong family history of diabetes or pre-existing diabetes. Prescription somatropin information therefore recommends monitoring glucose during treatment.
The interaction between growth hormone, insulin, glucose and fat metabolism is considerably more complicated than simply saying that “HGH raises blood sugar.” We will cover HGH and insulin resistance separately because it deserves a full article rather than a short side-effect section.
Can HGH Cause Diabetes?
It is more accurate to say that growth hormone can reduce insulin sensitivity and may contribute to the development or recognition of diabetes in susceptible individuals than to claim that everyone using HGH will develop diabetes.
Somatropin product information specifically warns that impaired glucose tolerance and previously undiagnosed diabetes can become apparent during treatment. New-onset type 2 diabetes has also been reported.
Individual risk depends on the broader metabolic picture. Genetics, body fat, diet, activity level, age, existing insulin resistance and the amount of growth hormone exposure can all affect how well the body maintains normal glucose control.
Someone receiving prescribed HGH may therefore have fasting glucose, HbA1c or other metabolic markers monitored as part of ongoing medical care.
Headaches and Intracranial Hypertension
A regular headache has many possible causes and does not automatically indicate a serious HGH complication. However, somatropin has rarely been associated with intracranial hypertension, meaning increased pressure around the brain.
Reported symptoms can include a persistent or severe headache, visual changes, nausea and vomiting. Swelling of the optic nerve, known as papilledema, can also occur and requires medical evaluation.
This adverse effect has been reported most often after treatment begins and is considered uncommon. Product prescribing information indicates that symptoms have generally resolved after somatropin was stopped or the prescribed dose was reduced.
A severe or persistent headache accompanied by vision changes, vomiting or other neurological symptoms should not be treated as an ordinary expected HGH side effect.
HGH and Thyroid Function
Growth hormone treatment can interact with thyroid hormone metabolism. In people with pituitary disorders, previously unrecognized central hypothyroidism can sometimes become apparent after growth hormone treatment begins.
This is particularly relevant because adults receiving HGH for true growth hormone deficiency may have deficiencies involving more than one pituitary hormone. A pituitary disorder affecting GH production can also affect thyroid-stimulating hormone, adrenal hormones or reproductive hormones.
For this reason, thyroid function may be monitored during medically supervised growth hormone treatment. A change in thyroid laboratory results does not necessarily mean that HGH directly damaged the thyroid gland; in some cases treatment reveals an existing hormonal deficiency that was previously less obvious.
This is another reason prescription HGH treatment is normally followed using laboratory testing rather than symptoms alone.
Injection-Site Reactions
Synthetic human growth hormone is administered by injection, so some side effects relate to the injection itself rather than the systemic effects of GH.
Redness, itching, discomfort or irritation can occur at an injection site. Repeatedly injecting into exactly the same location can also affect the fatty tissue beneath the skin, which is why prescribed injectable medications commonly include instructions for rotating injection sites.
Severe swelling, widespread rash, difficulty breathing or other signs of a serious allergic reaction require prompt medical attention. Serious hypersensitivity reactions to somatropin products have been reported, although they are not among the typical everyday effects experienced during treatment.
Specific injection and medication-handling instructions depend on the prescribed HGH product and should come from its manufacturer, pharmacist or prescribing healthcare professional.
Does HGH Cause Gynecomastia?
Gynecomastia, or enlargement of male breast tissue, has been reported in association with HGH treatment, although it is not one of the defining or most common adult HGH side effects.
Breast tissue is influenced by several hormones, and gynecomastia has numerous potential causes. Testosterone, estrogen, medications, body fat, liver function and other endocrine conditions can all influence breast tissue.
For that reason, breast enlargement in someone using HGH should not automatically be attributed to growth hormone. Persistent tenderness, a new lump or noticeable breast enlargement should be assessed appropriately rather than self-diagnosed based on HGH use alone.
Are HGH Side Effects Dose Dependent?
Many of the fluid-related adverse effects of somatropin appear to be dose dependent. Edema, joint discomfort, muscle pain, tingling and carpal tunnel symptoms are particularly associated with the fluid-retaining effects of growth hormone.
This is one reason medically prescribed adult growth hormone replacement is individualized. The goal in treating diagnosed growth hormone deficiency is not to produce the highest possible IGF-1 level or the most noticeable physical effects. Treatment is intended to restore appropriate growth hormone activity while minimizing adverse effects.
Age, body size, individual sensitivity, other medications and existing medical conditions can all influence a patient’s response. Prescribing information therefore allows healthcare professionals to adjust treatment according to clinical response, side effects and laboratory monitoring.
Using more HGH does not simply produce more of the desired effects while leaving risk unchanged.
HGH Side Effects vs Too Much Growth Hormone
There is an important distinction between short-term side effects of synthetic HGH and the consequences of chronically excessive growth hormone.
A person receiving prescribed somatropin may experience temporary swelling or joint discomfort without developing the physical changes associated with years of severe GH excess. Conversely, people with acromegaly experience persistently excessive GH production, usually because of a pituitary tumour.
Long-term untreated acromegaly can cause enlargement of the hands and feet, changes in facial structure, thickening of tissues and enlargement of internal organs. It is also associated with increased risk of conditions including hypertension, diabetes, sleep apnea and cardiovascular disease.
These consequences demonstrate that chronically excessive growth hormone is not benign, but they should not be used to imply that every person receiving medically supervised HGH replacement will develop acromegaly.
The duration, severity and biological context of GH exposure matter.
HGH and Cancer Risk
Growth hormone and IGF-1 participate in cell growth, which has led to longstanding questions about HGH and cancer. The issue is considerably more nuanced than the simple claim that “HGH causes cancer.”
Prescription somatropin is generally not used in the presence of active malignancy, and people with a history of certain tumours may require additional monitoring. This is particularly relevant when growth hormone deficiency resulted from a tumour or previous cancer treatment involving the pituitary or brain.
Clinical warnings also discuss the possibility of tumour recurrence or second neoplasms in specific high-risk populations, especially people who received radiation treatment during childhood. These observations cannot simply be generalized into a claim that prescribed HGH causes cancer in otherwise healthy adults.
Cancer history is therefore something that should be discussed with the prescribing physician before growth hormone treatment rather than evaluated through broad claims found online.
What About Long-Term HGH Use?
One limitation in discussions about HGH safety is that the evidence differs substantially depending on why HGH is being used. There is extensive clinical experience with medically supervised growth hormone replacement in patients with diagnosed deficiency, but much less reliable long-term information about supraphysiological HGH use in healthy adults.
That makes it difficult to estimate the exact risk of years of HGH exposure outside medically indicated treatment. Short studies can identify common effects such as edema, joint discomfort and changes in insulin sensitivity but cannot reliably answer every question about long-term cardiovascular, metabolic or cancer outcomes.
The absence of definitive long-term evidence should not be interpreted as proof of either complete safety or inevitable harm.
This is particularly important when comparing medically supervised replacement therapy with HGH use intended solely for physique, athletic performance or anti-aging purposes. They are not necessarily equivalent levels of hormone exposure.
When Should HGH Side Effects Be Taken Seriously?
Mild swelling or transient stiffness may occur during prescribed growth hormone treatment, but certain symptoms deserve more prompt medical assessment. Persistent neurological symptoms, significant hand weakness, severe swelling, major changes in glucose control or symptoms suggesting an allergic reaction should not simply be watched indefinitely.
A severe persistent headache accompanied by vision changes, nausea or vomiting is particularly important because of the rare association between somatropin and intracranial hypertension.
People receiving prescription HGH should also attend scheduled follow-up appointments even when they feel well. Some metabolic changes, including reduced insulin sensitivity, can develop before obvious symptoms appear.
Monitoring allows treatment decisions to be based on clinical findings and appropriate laboratory results rather than relying entirely on subjective changes in appearance or how someone feels.
The Bottom Line
HGH can cause side effects in adults, and many of the most common ones are connected to fluid retention. Swollen hands or ankles, joint and muscle discomfort, numbness, tingling and carpal tunnel syndrome are recognized effects of prescription somatropin and may be more noticeable when growth hormone exposure is higher.
Growth hormone can also reduce insulin sensitivity, making blood glucose an important consideration during treatment. Less common but more significant concerns include intracranial hypertension, serious hypersensitivity reactions and interactions with other pituitary hormone deficiencies.
Not every symptom that appears while someone is using HGH is necessarily caused by growth hormone, and the risks of medically supervised replacement should not be confused with the consequences of uncontrolled long-term GH excess. The safest interpretation comes from looking at symptoms, medical history, hormone levels and appropriate laboratory testing together.
Human growth hormone has legitimate medical uses, but its biological effects are powerful enough that side effects and monitoring matter. More HGH is not automatically better, and noticeable side effects should not be considered proof that the hormone is “working.”
Medical Disclaimer
This article is for educational and informational purposes only and is not medical advice. Human growth hormone (HGH) is a prescription medication in Canada and should only be used under the supervision of a qualified healthcare professional. Always consult a healthcare provider regarding diagnosis, treatment, medication use, dosing, side effects or concerns about growth hormone.